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med.sa (A.K. AlYahya).Afaf A. Bin-Khathlan, MD, MPH, FAIHQ, CHRM a,⇑; Fatin N. Al-Ballaa, MD b; Abdullah K. AlYahya, MD cAbstractPurpose: Study the ophthalmic morbidities for infants born prematurely at a Tertiary care center in Riyadh city.
Methods: Retrospective, longitudinal cohort study at King Fahad Medical City for premature infants born at gestational age (GA)
632 weeks or birth weight (BW) 61500 g during the study period from January 1, 2007, until the end of December 2009 was con-
ducted. Short term outcome was diagnosis with Retinopathy of Prematurity (ROP) and long-term outcome was ophthalmic findings
at age 18–24 months.
Results: The cumulative incidence of ROP was 30%. Infants diagnosed with ROP had a mean GA of 27 weeks (23–35 weeks) and
mean BW of 907 g (530–1730 g). Risk factors other than GA and BW for ROP, identified in the predictive logistic regression model,
were blood transfusion [odds ratio (OR) 1.27] and diagnosis with intraventricular hemorrhage (OR = 2.90). Strabismus was identi-
fied in 14% of the study cohort. Diagnosis of hyperopia (spherical equivalent P+0.75 D) was equal in both ROP and no-ROP
groups (p = 0.56). Myopia (spherical equivalent P0.75 D) and astigmatism P1.00 D were diagnosed more frequently in the
ROP group (p < 0.0001 and 0.04, respectively).
Conclusions: A higher incidence of ROP was observed in this cohort compared to some Saudi Arabian centers. It is recommended
that the screening criteria be maintained and that the effects of further control of blood transfusion be assessed in a prospective
study. The authors recommend an extra ophthalmic evaluation at the age of 18–24 months for all premature infants born with
GA 6 32 weeks.
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The rate of survival of premature infants is increasing
worldwide, with different types of disabilities associated with
extreme premature birth, including neurodevelopmental
delay and visual disabilities. Further follow-up is required
after discharge from the neonatal intensive care unit (NICU)
for early diagnosis and management of the associatedmorbidities. Still, controversies persist concerning the need
for further ophthalmic follow-up after discharge from the
Retinopathy of Prematurity (ROP) screening program in Saudi
Arabia, which remain to be addressed. Screening and
treatment of ROP have been well defined since publication
of the Cryotherapy for Retinopathy of Prematurity
(CRYO-ROP) study preliminary results and the revised
indication for treatment from the Early Treatment Retinopa-e:
al.com
.kfmc.
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Saudi Arabia over the last 10 years have shown variability in
the incidence of ROP from 23.31% to 56%.3–6 Those
variations are most probably related to differences in clinical
care provided among NICUs and differences in mean
gestational age (GA) and mean birth weight (BW) of the
respective studies.
Long-term outcomes for premature infants have not yet
been evaluated in Saudi Arabia, and the region lacks specific
recommendations to address the ophthalmic and non-
ophthalmic long-term outcomes for this high-risk population
even though studies have indicated significant ophthalmic
morbidities in this group.7–10 The relative risk for developing
myopia or hypermetropia in infants born with a BW of
61500 g is higher than that of the full-term population as
was previously published.11
The high-risk follow-up (HR) program at King Fahad Med-
ical City (KFMC) is unique and was introduced by the neona-
tology department for extremely premature infants with
high-risk characteristics for neurodevelopmental delays. The
pediatric ophthalmologists play a major part in this HR pro-
gram for the early diagnosis and management of ophthalmic
morbidities associated with premature birth, in both the ROP
screening and treatment program and screening for refrac-
tive errors and strabismus. The HR-KFMC is the first in the
region, making it the best source for data to generate recom-
mendations addressing post-NICU follow-up for ophthalmic
and non-ophthalmic outcomes. To our knowledge, this study
is the first from the country evaluating the long-term ophthal-
mic outcomes in premature infants born in a single tertiary
care center in Saudi Arabia.Methods
The study period was conducted from the first of January
2007 until the end of December 2009. Data were collected
from the infant’s file, which contain special ophthalmic evalu-
ation forms for both ROP and high-risk ophthalmic programs
at KFMC (HR-ROP). The study was performed in two parts to
address short-term and long-term ophthalmic outcomes. GA
was calculated from the last menstrual cycle until birth in
weeks, and post-menstrual age (PMA) was calculated as
GA + chronological age in weeks.Short term outcome
Premature infants born at KFMC during the study period
with BW 6 1500 g or GA 6 32 weeks who were referred for
ROP screening and survived until the first screening were
included in this part of the study. Infants born elsewhere
and referred for neonatal care or for LASER therapy or who
were outside the screening criteria and referred for other rea-
sons were excluded from this part of the study.
The initial ROP screening exam was done in the NICU at
4–6 weeks of chronological age, and rescreening was done
every 1–3 weeks based on ROP stage. Infants were dis-
charged from screening when the retina was fully vascular-
ized, ROP had regressed, or the infant reached 45 weeks
PMA without any ROP.
Screening was done by either of the two study authors
(AK, FB), and inter-examiner agreement was maintained.
The screening was carried out in the NICU after installationof cyclopentolate 1% eye drops and phenylephrine 2.5% in
both eyes to dilate the pupils. A lid speculum and lens loop
were used to open the eye and rotate the globe to aid exam-
ination of the peripheral retina. Indirect ophthalmoscopy was
performed using a 28 D–aided visualization of zone 3 of the
retina. If the retinal examination could not be done on
the booked date because of an unstable general condition,
the exam was done as soon as the neonatologist deemed it
safe. ROP staging was documented on the screening form
following the International Classification of Retinopathy of
Prematurity.12 The form contains entries for GA, BW, and
chronological age at examination in days, demographic data
for the infant, ventilation days (ventilation days + continuous
positive pressure days), total oxygen therapy days (days ven-
tilated + nasal cannula days), blood transfusion amount, and
single or twin birth. The infants were followed until the crite-
ria for treatment were met based on the recommendation of
ETROP or vascularization of the retina was observed.2 Severe
ROP was defined as Pstage 3 ROP. Infants discharged from
the NICU to home or to other medical centers for weight gain
care prior to screening initiation or prior to PMA 45 weeks
were given an outpatient visit with the primary investigator
(AK) in the HR-ROP clinic.
Risk factors for ROP analyzed in this study were GA, BW,
sex, single or multiple pregnancy, blood transfusion, intra-
ventricular hemorrhage diagnosis (IVH), culture-positive sep-
ticemia, culture positive candidemia, necrotizing enterocolitis
(NEC) diagnosis, total ventilation days, total oxygen therapy
days, APGAR score at 1 and 5 min, maximum base excess in
the first 12 h of life, and oxygen therapy by maximum and
minimum fraction of inspired Oxygen (FiO2) in the first 12 h.
A new variable was created to study the effect of using high
FiO2 at resuscitation by calculating the FiO2 drop from max-
imum to minimum in the first 12 h of the infant’s life.Long-term outcome
Premature infants in the ROP program were included in
this part of the study. The HR-ROP ophthalmic follow-up
was offered to the parents of all infants at 8 months
for orthoptic evaluation and at 18–24 months of age for
cyclorefraction. Infants who did not show at follow-up for
18–24 months visit were excluded from this part of the study.
At each visit, special ophthalmic forms were completed, as
follows. (1) An orthoptic evaluation form was completed at
the 8-month visit with fixation preference, extraocular muscle
motility, deviation by cover–uncover tests, red reflex, and
four-prism test in cooperative children. This part of the pro-
gram was done by a trained optometrist. If any abnormality
was found, a full evaluation was done by the pediatric oph-
thalmologist on the same day. (2) An ophthalmic evaluation
form was completed, containing history, medications, and
posterior pole evaluation using a physician form and the
orthoptic form. Refraction was done by the optometrist using
a negative cylinder after 45 min from installing cyclopento-
late 1% and phenylephrine 2.5% in both eyes. Infants with a
history of convulsion or psychomotor delays were not offered
cyclopentolate; instead, refraction was done at 30 min follow-
ing tropicamide 1% installation to avoid neurological compli-
cations in this high-risk population.
Refractive errors were categorized based on the spherical
equivalent (SE), which was calculated by summing the power
270 A.A. Bin-Khathlan et al.of the sphere to half the power of the cylinder. Emmetropia
was diagnosed if the refraction results were between +0.50
and 0.50 D. Astigmatism was considered significant if
P1.00 D was found in the worse eye; it was labeled as with
the rule (WTR) if the negative cylinder lens axis was at
180 ± 15 and against the rule if the negative cylinder lens
axis was at 90 ± 15; the intervening correction axes were
classified as oblique astigmatism. Anisometropia was diag-
nosed if the difference in SE between the two eyes was
>1.00 D.9 Only the refraction findings at 18–24 months were
used in this part of the analysis.
Ethics approval
Ethics approval was obtained from the internal review
board at KFMC, the head of the NICU, and the director of
the HR program. Parents or other caregivers for all infants
also gave written consent to be screened for ROP, and
attending at the long-term visit was their consent for the
long-term outcome part of the study.
Statistical analysis
The collected data were evaluated with the StatsDirect
statistical package using an Excel spreadsheet. Cumulative
incidence of any ROP and severe ROP was calculated.
Descriptive statistics for different risk factors were carriedStudy cohort: 3
infants born 
346 premature infants 
referred for ROP screening in 
NICU
243 infants  
no-ROP 
103 infa
ROP
231 at refraction visit at >18 
months; one case removed for 
unilateral surgical aphakia
256 at 8-month visit for orthoptic 
evaluation
21 in
155
Figure 1. Flow chart oout for each variable: standard deviation was calculated,
and the p value was set at <0.05. Relationships involving
two discrete variables were evaluated using the chi-squared
or Fisher’s exact test and 95% confidence intervals (CIs) were
recorded. Pregnancy type was dichotomized as single or twin
pregnancy, and analysis was done using the difference in pro-
portions. Unpaired t-test analysis was followed to evaluate
continuous variables; if the two-sided test was significant,
the approximate t-test results were used.
Univariate logistic regression analysis was done for all risk
factors included in this part of the study, and a predication
model was created using the significant risk factor from the
univariate analysis with backward elimination of non-signifi-
cant variables. Squint cumulative incidence and associated
risk factors were analyzed using the chi-square test or Fisher’s
exact test when appropriate. Risk factors for squint that was
analyzed include GA, BW, diagnosis with ROP, and IVH diag-
nosis. The frequencies of refractive errors were recorded
after categorization of the refraction findings.
Results
The total number of in-center–born infants referred for
ROP screening from the NICU team was 360 during the study
period. The cohort had a mean GA = 30 weeks (23–36 weeks)
and BW = 1210 g (530–2110 g). Fig. 1 shows the flow chart of
the cohort in the study.60 preterm 
at center
nts 
14 premature infants 
discharged prior to 
screening 
220 infants had no 
squint
36 infants had squint
55 infants had no refractive 
errors
fants with myopia > -0.50
 infants with hyperopia >+0.50
f the study cohort.
Table 1. Demographic characteristics of the study cohort.
ROP NO ROP p value
Total number 103 (30%) 243 (70%)
Mean GA, week 27 (SD = 2.5) 31 (SD = 2.1) <0.0001
Mean BW, g 907 (SD = 232.5) 1346 (SD = 308.6) <0.0001
Mean of amount of blood transfused, cc 85 (SD 74) 13 (SD 27) <0.0001
Mean ventilation, days 35 (SD 33) 6 (SD 10) <0.0001
Mean total oxygen, days 58 (SD 50) 12 (SD 17) <0.0001
Mean maximum base excess in first 12 h 7 (SD 4) 6 (SD 4) =0.0037
Mean minimum FiO2
a 27% (SD 11%) 23% (SD 5%) =0.0003
Mean maximum FiO2
a 59% (SD 29%) 45% (SD 25%) <0.0001
Drop of maximum FiO2
a 44% (SD 25%) 39% (SD 26%) =0.0038
Twin pregnancy 42/103 (41%) 118/243 (49%) =0.16
Male sex 54/103 (52%) 138/243 (57%) =0.41
a Fraction Inspired Oxygen in the first 12 h after birth.
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Figure 2. ROP proportion by gestational age at birth in weeks.
Ophthalmic short- and long-term outcomes for premature infants 271A total of 14 cases were transferred to another hospital for
weight gain or discharged home prior to the first evaluation
and never attended the outpatient appointments or the
HR-ROP follow-up program and were not included in the
final analysis. Those infants had mean GA = 31 weeks
(28–34 weeks) and mean BW = 1385 g (868–1935 g).Short term outcome results
The cumulative incidence of any ROP in the study cohort
was 30%. Table 1 shows demographic characteristics and risk
factor analysis of the infants with and without ROP and the
results of the unpaired t-test p values. The ROP group BW
ranged between 530–1730 g, and GA range was
23–35 weeks. The cumulative incidence of ROP went up to
47% when the GA fell to 630. Prophylaxis LASER therapy
was indicated in 3% of the study population.
The highest incidence of ROP was found in the 624 weeks
GA group (100%), and the lowest was in the >32 weeks GA
group (6%) as shown in Fig. 2. The median PMA at ROP diag-
nosis in the study cohort was 35 weeks (from 31 to 43 weeks),Table 2. Distribution of ROP types with corresponding GA and BW.
Number (%) M
Stage 1 47 (13.5) 2
Stage 2 33 (9.5) 2
Stage 3 23 (7) 2
LASER therapy 9 (3) 2with eight infants diagnosed with ROP at PMA P40 weeks
because of poor general condition, delaying timely screening
at 32 weeks PMA. Severe ROP cumulative incidence was 7%
with a mean GA of 25 weeks (from 23 to 29 weeks) (Table 2).
Sex as a risk factor for ROP was not significantly associated
with the disease by logistic regression analysis (odds
ratio = 1.19, 95% CI 0.75–1.89). Table 3 shows the significant
risk factors with their odds ratios by logistic regression
analysis.
A ROP prediction model was constructed using the iden-
tified significant risk factors with backward elimination. The
final model included IVH diagnosis with the highest odds
ratio of 2.90 (Table 4).
Long-term outcome results
A total of 256 infants attended at the 8-month (optome-
trist). In the ROP group, 73% were present for the 8-month
visit (75/103), and 75% attended from the no-ROP group
(181/243). Squint was diagnosed in 36 infants with a
cumulative incidence of 14%, with mean GA = 27 weeks
(23–34 weeks). Esotropia was diagnosed in 10% (25/256)
overall and in 20% of the ROP group (15/75) and 5.5% of
the no-ROP group (10/181). Exotropia diagnosis was made
in 4% (11/256) of infants, with an incidence in the ROP
group of 11% (8/75) and 2% (3/181) in the no-ROP group.
Mean corrected age at squint diagnosis was 15 months
(8–58 months). Table 5 shows the significant risk factors
associated with squint diagnosis for the study.
At the 18–24 month visit (the orthoptic and refraction
visit), 231 infants were present; one infant with unilateral
surgical aphakia from the ROP group was removed from
analysis, leaving a total of 74 infants (73%) from the 103 in
the ROP group; and 156 infants (64%) from the 243 in the
no-ROP group attending this visit.
Significant refractive error (P0.75 orP+0.75) was diag-
nosed in 24% of this cohort. High refractive errors (>3.00 or
>+3.00 D) were found in 13% (30/231) of the infants
analyzed; Fig. 3 shows the SE in the worse eye by GA. Theean GA in g (range) Mean BW in week (range)
8 (23–35) 1004 (660–1460)
7 (23–35) 876 (530–1730)
5 (23–29) 751 (548–1000)
5 (24–28) 800 (660–1000)
Table 3. Logistic regression analysis of risk factors.
Estimate Odds ratio 95% CI
GA weeks (for every 1 week increase) 0.67 0.51 0.44–0.59
BW g (100 g increase) 0.65 0.52 0.45–0.60
Blood transfusion (15 cc) 0.53 1.70 1.48–1.92
Ventilation (for every 1 day increase) 0.09 1.09 1.07–1.11
Total oxygen (for every 1 day increase) 0.06 1.06 1.05–1.08
Diagnosis with candidemia 2.18 8.88 1.81–43.50
Diagnosis with septicemia 1.63 5.12 3.07–8.56
NEC diagnosis 2.24 9.36 3.00–29.19
Diagnosis with IVH 2.15 8.55 4.64–15.77
APGAR score at 1 min 0.28 0.76 0.67–0.86
APGAR score at 5 min 0.55 0.58 0.47–0.71
Maximum base excess 67 0.58 1.79 1.12–2.87
Minimum FiO2
a 0.07 1.08 1.037–1.113
Maximum FiO2
a 0.019 1.02 1.010–1.028
Diagnosis with jaundice 0.81 2.25 1.19–4.23
Maximum FiO2
a drop 0.01 1.01 1.004–1.022
a Fraction Inspired Oxygen in the first 12 h after birth.
Table 4. Logistic regression prediction model for ROP.
Pseudo R-squared = 0.48 Estimate OR 95% CI
GA (week) 0.23 0.79 0.67–0.94
BW g (100 g change in birth weight) 0.36 0.70 0.59–0.83
Blood transfusion (for 15 cc change in transfusion volume) 0.236 1.27 1.12–1.43
Diagnosis with IVH 1.062 2.90 1.27–6.61
Table 5. Fisher’s exact test results for risk factors for squint diagnosis.
OR 95% CI
Diagnosis with IVH 7.05 3.09–16.06
Diagnosis with ROP 4.41 1.99–10.05
BW 6 1200 g 2.80 1.23–6.80
GA 6 30 weeks 4.13 1.51–14.08
0
10
20
30
40
50
60
70
80
90
100
NONE 1.00 to 1.75 2.00 to 2.25 > 2.50
N
um
be
r o
f i
nf
an
ts
ROP (74) NO ROP (157)
Figure 4. Frequency of astigmatism by ROP diagnosis.
272 A.A. Bin-Khathlan et al.proportions of infants with hyperopiaP0.75 D were equal in
the two groups (65% vs. 68%; p = 0.56) while the ROP group
was diagnosed more frequently with myopiaP0.75 (22% vs.
3%; p < 0.0001).
Astigmatism cumulative incidence was 50% (106/231)
overall. In the ROP group, 55% (41/74) of infants had astig-
matism while 41% (65/157) of infants in the no-ROP group
were diagnosed with astigmatism P1 D; the proportion in
the ROP group was significantly higher (p = 0.04). The major-
ity of astigmatism (71%) (165/231) was WTR. High astigma-
tism (P2.50 D) was confirmed in three infants (1.3%), and
two of these cases were in the ROP group. Fig. 4 showsFigure 3. Spherical equivalent by gestational age at birth for the
18–24 month visit.the distribution of astigmatism diagnosis in both the ROP
and no-ROP groups. Anisometropia was identified in six
infants (2.6%) with five infants from the ROP group, but
because of the number of cases, no further analysis was con-
ducted related to this outcome.Discussion
The goal of this study was to evaluate the short-term and
long-term ophthalmic morbidities associated with premature
birth. In this study cohort, ROP was not a cause of blindness.
Abnormal fixation patterns in infants at 2 years of age were
secondary to central visual pathway involvement, severe
refractive errors, or squint.
The screening and treatment criteria for ROP at KFMC
were shown to be appropriate. All infants diagnosed with
stage 3 ROP were below the current GA and BW criteria
(Table 2). The mean GA and BW for the study cohort were
similar to the distribution in other publications from the coun-
try.3–6
Ophthalmic short- and long-term outcomes for premature infants 273The risk factors for ROP identified in the prediction model
for infants born at KFMC included blood transfusion and
diagnosis with IVH, which have not previously been reported.
Only one center in Saudi Arabia reported a significant predic-
tive effect of IVH on developing threshold disease.13 Com-
paring our NICU’s short-term ophthalmic morbidities to the
Vermont Oxford Network (VON) published data in 2007 from
premature infants born with BW 501–1500 g, our study
showed that the KFMC NICU falls between the 25th and
50th percentiles of contributing units based on the cumula-
tive incidence of any ROP and between 50th and 75th per-
centiles for severe ROP.14 The VON results are used as the
benchmark for the quality of care delivered in NICU. Based
on the current results, it is essential to lower the cumulative
incidence for ROP diagnosis in our unit through modifications
in clinical care. Blood transfusion control needs to be further
evaluated in a prospective study, and evaluation of other risk
factors was not included in this study.
The other part of improving premature infant outcome is
through control of oxygen delivery in FiO2 in the first 12 h.
A new variable was used to evaluate the effects of aggressive
resuscitation with high FiO2 in the delivery room the univari-
ate logistic regression showed that a 1% drop in FiO2 from
maximum in the first 12 h of the infant’s life was associated
with a 1% increase in the odds of developing ROP (Table 3).
Controlling the liberal use of high FiO2 in the delivery room is
mandatory.15
Long-term ophthalmic outcome evaluation at the 18–
24 month visit was appropriate for identifying significant oph-
thalmic morbidities, as has been previously reported in other
publications.9,11,16 There were no significant differences in
the diagnosis with hyperopia between infants diagnosed with
or without ROP. Myopia and astigmatism, however, were
diagnosed more frequently in the ROP group, with a higher
incidence than have been reported internationally in prema-
ture infants and nationally in full-term infants.9,16,17 Strabis-
mus was less frequently identified in our cohort compared
to the international figures and was significantly predicted
by IVH diagnosis based on Fisher’s exact test analysis of risk
factors for strabismus diagnosis (Table 4) mandating further
ophthalmic evaluation for this group of infants11,18.
We recommend further evaluation at the age of 18–24
months for all premature infants born with GA 6 32 weeks.
In addition, increasing the GA criteria for inclusion in the
HR ophthalmic follow-up program from 632 to 634 weeks
needs further evaluation in a cost effective analysis prior to
implementation country wide.
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